by Vandana Singh | Jan 30, 2026 | General
Novo Nordisk A/S (NYSE:NVO) is accused of unlawfully extending its monopoly over its diabetes drug Victoza through a multiyear anticompetitive scheme designed to delay generic competition. • What’s ahead for NVO stock? The class action complaint, filed in the U.S....
by Henry Khederian | Jan 30, 2026 | General
Joby Aviation Inc (NYSE:JOBY) shares are trading flat Friday morning after a sharp selloff earlier this week, following the company’s announcement of an upsized $1.18 billion public offering. Shares have fallen roughly 15% since Wednesday. Here’s what...
by Benzinga Insights | Jan 30, 2026 | General
In the dynamic and fiercely competitive business environment, conducting a thorough analysis of companies is crucial for investors and industry enthusiasts. In this article, we will perform an extensive industry comparison, evaluating Micron Technology (NASDAQ:MU) in...
by Benzinga Insights | Jan 30, 2026 | General
SoFi Techs (NASDAQ:SOFI) released fourth-quarter financial results and hosted an earnings call on Friday. Read the complete transcript below. This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog, please visit...
by Benzinga Insights | Jan 30, 2026 | General
Charter Communications (NASDAQ:CHTR) reported fourth-quarter financial results on Friday. The transcript from the company’s fourth-quarter earnings call has been provided below. This content is powered by Benzinga APIs. For comprehensive financial data and...
Recent Comments